The Latest in HCV Hub

PCORI approves $83 million for HCV, rare disease research

September 29, 2015

Hepatitis

Sofosbuvir-velpatasvir combo effective in all HCV genotypes

September 23, 2015

Hepatitis

Smartphone app can pick up covert hepatic encephalopathy

September 9, 2015

Integrated care overcomes HCV treatment barriers

September 8, 2015

Hepatitis

Hepatitis E linked to 1 in 10 liver failure cases in Europe

September 4, 2015

Virologic response no protection against HCV liver decompensation

September 3, 2015

Hepatitis

Ledipasvir-sofosbuvir plus ribavirin in advanced HCV does well

September 1, 2015

Cirrhosis in HCV often goes unreported

August 29, 2015

Hepatitis

FDA approves Daklinza for HCV genotype 3 infections

July 24, 2015

FDA approves oral interferon-free treatment for genotype 4 HCV infection

July 24, 2015

Georgia launches HCV elimination program

July 23, 2015

Ledipasvir plus sofosbuvir achieve excellent response in HCV/HIV coinfection

July 21, 2015

Daclatasvir plus sofosbuvir safe and effective in HCV/HIV coinfection

July 21, 2015

Online recommendations provide constantly updated HCV management guidelines

June 26, 2015

DDW: Single daily pill knocks out HCV in prior nonresponders

June 19, 2015